The authors regret an error was included in the published funding information for this article. The correct funding information is:
This work was supported by the CAMS Innovation Fund for Medical Sciences (CIFMS) [2021-I2M-1-017] & [2021-I2M-C&T-B-080], Tianjin Municipal Science and Technology Commission Grant (21JCZDJC01170) and Haihe Laboratory of Cell Ecosystem Innovation Fund [HH22KYZX0036].
Table S3 was also included in the supplementary material in error.
The authors would like to apologize for any inconvenience caused.
Article info
Publication history
Published online: January 17, 2023
Publication stage
In Press Journal Pre-ProofIdentification
Copyright
© 2023 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association.
User license
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) | How you can reuse 
Elsevier's open access license policy
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0)
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy
ScienceDirect
Access this article on ScienceDirectLinked Article
- Utility of plasma cell-free DNA next-generation sequencing for diagnosis of infectious diseases in patients with hematological disordersJournal of InfectionVol. 86Issue 1
- PreviewNeutropenia is an independent risk factor for infection in patients with hematological disorders who have undergone hematopoietic stem cell transplantation (HSCT) and received cytotoxic chemotherapy or immunosuppressive therapy.1-3 Infection is one of the most common complications for patients with neutropenia and can lead to high mortality if inappropriate empirical antibiotic treatment is administered.4, 5 Accurate and timely pathogen detection is critical in optimizing antibiotic use; however, it is challenging in patients with neutropenia because of nonspecific clinical symptoms, signs, and the low positivity rate of conventional microbiological tests (CMT).
- Full-Text
- Preview
